# Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts

> **NCT02098226** · — · UNKNOWN · sponsor: **Bruker Daltonics** · enrollment: 3000 (estimated)

## Conditions studied

- Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02098226
- **Lead sponsor:** Bruker Daltonics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2014-09
- **Final completion:** 2015-03
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2015-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02098226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02098226, "Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02098226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*